3 Reasons SATS is Risky and 1 Stock to Buy Instead
Over the last six months, EchoStar shares have sunk to $22.63, producing a disappointing 12.3% loss - worse than the S&P 500’s 6.9% drop. This might have investors contemplating their next move.
Apparel and Accessories Stocks Q4 Recap: Benchmarking PVH (NYSE:PVH)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at PVH (NYSE:PVH) and the best and worst per
3 Reasons GILD is Risky and 1 Stock to Buy Instead
In a sliding market, Gilead Sciences has defied the odds, trading up to $106.42 per share. Its 24% gain since October 2024 has outpaced the S&P 500’s 6.9% drop. This was partly due to its solid quar
Winners And Losers Of Q4: KLA Corporation (NASDAQ:KLAC) Vs The Rest Of The Semiconductor Manufacturing Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at KLA Corporation (NASDAQ:KLAC) and its peers.
Software Development Stocks Q4 Recap: Benchmarking PagerDuty (NYSE:PD)
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the software development industry, including PagerDuty (NYSE:PD) and its peers.
Safety & Security Services Stocks Q4 Results: Benchmarking GEO Group (NYSE:GEO)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at GEO Group (NYSE:GEO) and its peers.
Electronic Components Stocks Q4 Teardown: Allient (NASDAQ:ALNT) Vs The Rest
Looking back on electronic components stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Allient (NASDAQ:ALNT) and its peers.
Beverages, Alcohol, and Tobacco Stocks Q4 In Review: Altria (NYSE:MO) Vs Peers
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how beverages, alcohol, and tobacco stocks fared in Q4, starti
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Exact Sciences (NASDAQ:EXAS) and its peers.
Winners And Losers Of Q4: ASGN (NYSE:ASGN) Vs The Rest Of The IT Services & Consulting Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ASGN (NYSE:ASGN) and the best and worst p